Abstract:For infectious diseases, rapid and accurate identification of the pathogen is critical for effective management and treatment, but diagnosis remains challenging, particularly in resource-limited areas. Methods that accurately detect pathogen nucleic acids can provide robust, accurate, rapid, and ultrasensitive technologies for point-of-care diagnosis of pathogens, and thus yield information that is invaluable for disease management and treatment. Several technologies, mostly PCR-based, have been employed for pathogen detection; however, these require expensive reagents and equipment, and skilled personnel. CRISPR/Cas systems have been used for genome editing, based on their ability to accurately recognize and cleave specific DNA and RNA sequences. Moreover, following recognition of the target sequence, certain CRISPR/Cas systems including orthologues of Cas13, Cas12a, and Cas14 exhibit collateral nonspecific catalytic activities that can be employed for nucleic acid detection, for example by degradation of a labeled nucleic acid to produce a fluorescent signal. CRISPR/Cas systems are amenable to multiplexing, thereby enabling a single diagnostic test to identify multiple targets down to attomolar (10-18 mol/L) concentrations of target molecules. Developing devices that couple CRISPR/Cas with lateral flow systems may allow inexpensive, accurate, highly sensitive, in-field deployable diagnostics. These sensors have myriad applications, from human health to agriculture. In this review, we discuss the recent advances in the field of CRISPR-based biosensing technologies and highlight insights of their potential use in a myriad of applications.

CRISPR/Cas-based nucleic acid detection strategies: Trends and challenges

Advances and Challenges of Signal Readout Systems in CRISPR-based Biosensors for Point-of-care Testing of Nucleic Acid

Advances in Amplification-Free Detection of Nucleic Acid: CRISPR/Cas System As a Powerful Tool.

CRISPR/cas systems redefine nucleic acid detection: Principles and methods

CRISPR Cas system: A strategic approach in detection of nucleic acids

Harnessing CRISPR/Cas Systems for DNA and RNA Detection: Principles, Techniques, and Challenges

Recent Advances and Challenges of the Use of the CRISPR/Cas System As a Non-Nucleic Acid Molecular Diagnostic

Versatile Detection with CRISPR/Cas System from Applications to Challenges

Novel nucleic acid detection strategies based on CRISPR‐Cas systems: From construction to application

Novel Non-Nucleic Acid Targets Detection Strategies Based on CRISPR/Cas Toolboxes: A Review

Application of CRISPR/Cas Technology in Biological Nano‐Analysis

Towards application of CRISPR-Cas12a in the design of modern viral DNA detection tools (Review)

The CRISPR/Cas System: A Customizable Toolbox for Molecular Detection

Molecular Mechanisms Underlying CRISPR/Cas-Based Assays for Nucleic Acid Detection

CRISPR-Cas Biochemistry and CRISPR-Based Molecular Diagnostics.

Nucleic Acid Detection Using CRISPR/Cas Biosensing Technologies

CRISPR/Cas systems for the detection of nucleic acid and non-nucleic acid targets

CRISPR: The Frontier Technology of Next-Generation RNA Detection

Pathogen Detection Strategy Based on CRISPR

[Application of CRISPR/Cas-based Biosensors for Detecting Nucleic Acid of Pathogens].

Recent progress in aptamer and CRISPR-Cas12a based systems for non-nucleic target detection.